Entry Point Capital, LLC Merck & Co., Inc. Transaction History
Entry Point Capital, LLC
- $221 Million
- Q4 2024
A detailed history of Entry Point Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 2,631 shares of MRK stock, worth $244,972. This represents 0.12% of its overall portfolio holdings.
Number of Shares
2,631
Previous 4,386
40.01%
Holding current value
$244,972
Previous $498,000
47.59%
% of portfolio
0.12%
Previous 0.29%
Shares
3 transactions
Others Institutions Holding MRK
# of Institutions
3,972Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$23.4 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.3 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$11.3 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.52 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.7 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $236B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...